Dvision(300167)2023-04-26 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥51,878,243.41, a decrease of 50.58% compared to ¥104,979,496.54 in the same period last year[5] - The net loss attributable to shareholders was ¥50,653,586.25, representing a 34.13% increase from a loss of ¥37,763,221.20 in the previous year[5] - The net profit for Q1 2023 was -53,358,531.48 CNY, compared to -38,450,394.39 CNY in Q1 2022, representing an increase in net loss of approximately 38.5%[17] - The company reported a total comprehensive loss of -53,358,531.48 CNY for the quarter, compared to -38,450,394.39 CNY in the same period last year[18] - Basic and diluted earnings per share were both -0.1405, compared to -0.1158 in the previous year[18] Cash Flow - The net cash flow from operating activities improved by 21.74%, amounting to -¥18,385,435.29 compared to -¥23,494,043.73 in Q1 2022[5] - The net cash flow from financing activities was ¥3,252,599.05, a significant improvement from -¥5,630,156.39 in the same period last year[8] - The total cash flow from operating activities was -18,385,435.29 CNY, improving from -23,494,043.73 CNY year-over-year[21] - The total cash outflow from investing activities was -32,569.62 CNY, compared to -323,533.30 CNY in the previous year, indicating reduced investment outflows[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥672,724,483.50, a decrease of 5.01% from ¥708,209,463.10 at the end of the previous year[5] - Total liabilities decreased to CNY 568,776,430.03 from CNY 573,337,930.83 at the beginning of the year[15] - The company’s total current liabilities were CNY 495,288,539.92, slightly down from CNY 500,221,529.46 at the beginning of the year[15] - The company reported a net loss of CNY 716,322,203.21 in retained earnings, compared to a loss of CNY 665,668,616.95 at the beginning of the year[15] Research and Development - Research and development expenses increased by 90.94% to ¥3,641,710.03, up from ¥1,907,205.81 in the same period last year[8] - Research and development expenses increased to 3,641,710.03 CNY, up from 1,907,205.81 CNY, indicating a focus on innovation[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 19,716[10] Other Income and Expenses - The company experienced a 512.65% increase in other income, reaching ¥1,014,329.04 compared to ¥165,564.61 in the previous year[8] - The company incurred financial expenses of 1,666,346.89 CNY, an increase from 1,362,926.10 CNY in the previous period[17]